Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis
- 15 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurosurgical Review
- Vol. 44 (3), 1591-1600
- https://doi.org/10.1007/s10143-020-01348-6
Abstract
Intracranial anaplastic hemangiopericytoma (AHPC) is a rare and malignant subset of solitary fibrous tumor/hemangiopericytoma (SFT/HPC) as per the WHO 2016 Classification of Tumors of the Central Nervous System. AHPC portends a poor prognosis and is associated with higher rates of recurrence/metastasis in comparison with SFT/HPC. Accordingly, it is critical to continue to define the clinical course of patients with AHPC and in so doing further refine clinicopathologic/immunohistochemical (IHC) criteria needed for definitive diagnosis. Herein, we describe clinical/histological characteristics of six patients with AHPC. In addition, we reviewed and analyzed the expression of various IHC markers reported within the literature (i.e., a total of 354 intracranial SFT/HPCs and 460 meningiomas). Histologically, tumors from our six patients were characterized by a staghorn-like vascular pattern, mitotic cells, and strong nuclear atypia. Immunohistochemically, all tumors displayed positive nuclear staining for STAT6; other markers, including CD34 and Bcl-2, were expressed only in three patients. Analysis of IHC expression patterns for SFT/HPC and meningioma within the literature revealed that nuclear expression of STAT6 had the highest specificity (100%) for SFT/HPC, followed by ALDH1 (97.2%) and CD34 (93.6%). Of note, SSTR2A (95.2%) and EMA (85%) displayed a high specificity for meningioma. Anaplastic SFT/HPC is a tumor with poor prognosis that is associated with higher rates of recurrence and metastasis in comparison with SFT/HPC. Given that anaplastic SFT/HPC requires more aggressive treatment than meningioma despite of a similar presentation on imaging, it is crucial to be able to distinguish between these tumors.Keywords
This publication has 32 references indexed in Scilit:
- Primary intracranial haemangiopericytoma: Comparison of survival outcomes and metastatic potential in WHO grade II and III variantsJournal of Clinical Neuroscience, 2014
- Previously unrecognized pattern of central nervous system hemangiopericytoma with pseudoglandular spacesClinical Neuropathology, 2014
- A Strongly CD34-Positive Meningioma that was Difficult to Distinguish from a Solitary Fibrous TumorUltrastructural Pathology, 2014
- Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumorGenes, Chromosomes and Cancer, 2013
- ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling studyActa Neuropathologica Communications, 2013
- Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinActa Neuropathologica, 2013
- Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumorsNature Genetics, 2013
- Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencingNature Genetics, 2013
- CD34 immunoreactivity in nervous system tumorsActa Neuropathologica, 1994
- HEMANGIOPERICYTOMA A VASCULAR TUMOR FEATURING ZIMMERMANNʼS PERICYTESAnnals of Surgery, 1942